Editorial Board ::: Current Cancer Therapy Reviews

ISSN: 1875-6301 (Online)
ISSN: 1573-3947 (Print)


Volume 13, 2 Issues, 2017


Download PDF Flyer




Current Cancer Therapy Reviews

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Kurt S. Zaenker
Institute of Immunology and Experimental Oncology University Witten/Herdecke
Stockumerstraße 10, 58448 Witten
Germany


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Editorial Board

Editor-in-Chief:

Kurt S. Zaenker
Institute of Immunology and Experimental Oncology University Witten/Herdecke
Stockumerstraße 10, 58448 Witten
Germany



Associate Editor:

Franco M. Muggia
New York University Medical Center
New York, NY
USA


Regional Editors:

Region: Europe
D. Santini
Department of Medical Oncology University Campus Bio-Medico
Rome
Italy
Region: Norrth America
K. Camphausen
Radiation Oncology Department
National Institute of Health
Bethesda, MD
USA

Editorial Board Members:

R.J. Ablin
University of Arizona College of Medicine
Arizona
USA

D. Assimakopoulos
Univ. Ioannina Sch. Med.
Ioannina
Greece

E.E. Baulieu
INSERM U488
Le Kremlin Bicetre
France

J.R. Bertino
UMDNJ-Robert Wood Johnson Med. Sch
New Brunswick, NJ
USA

B. Bonavida
UCLA School of Medicine
Los Angeles, CA
USA

D.J. Buchsbaum
Univ. of Alabama at Birmingham
Birmingham, AL
USA

W. Carson
Ohio State University
Columbus, OH
USA

F. Ciardiello
Second University of Naples
Naples
Italy

V.P Collins
Addenbrooke's Hospital
Cambridge
UK

W.S Dalton
Univ. S Florida H Lee Moffitt Canc. Ctr.
Tampa, FL
USA

S.J. Day
John Wayne Canc. Inst
Santa Monica, CA
USA

L Dubeau
USC Keck Sch. Med
Los Angeles, CA
USA

R.J Fitzgibbons
Creighton University Medical Center
Omaha, NE
USA

S. Fuqua (Biography
S. Fuqua

Dr. Suzanne Fuqua received her Bachelor and Master of Science degrees from the University of Houston, and her PhD in Cancer Biology from the MD Anderson Cancer Center in Houston, Texas. She joined the the University of Texas Health Science Center at San Antonio as a postdoctoral fellow in 1985, attaining the position of tenured Associate Professor in 1994. Currently, she is a tenured Professor in the Lester and Sue Smith Breast Center at Baylor College of Medicine in Houston.

)

Baylor Coll. Med.
Houston, TX
USA

S. Garattini
Mario Negri Inst. Pharmacol. Res.
Milan
Italy

K Geboes
University Hospital KUL
Leuven
Belgium

L Gianni
Istituto Nazionale dei Tumori
Milan
Italy

M.J Glennie
Southampton Gen. Hosp.
Hants
UK

J.W Gratama
Erasmus Cancer Center
Rotterdam
The Netherlands)

R Hawkins
Univ. Manchester
Manchester
UK

E Hiyama
Hiroshima University
Hiroshima
Japan

M.D Incalci
Istituto di Ricerche Farmacologiche Mario Negri
Milan
Italy

J Jassem
Medical University of Gdansk
Gdansk
Poland

R Kalluri
Harvard Univ. Sch. Med
Boston, MA
USA

R Kurzrock
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

J Lunec
Univ. Newcastle upon Tyne
Newcastleupon Tyne
UK

J.D Marks
Univ. Calif. San Francisco General Hospital
San Francisco, CA
USA

H Mellstedt
Karolinska University Hospital Solna
Stockholm
Sweden

R Meredith (Biography
R Meredith

Ruby F. Meredith, MD, PhD is a Professor of Radiation Oncology at the University of Alabama at Birmingham. She is former Director of Research in that department, and a Senior Scientist at the University of Alabama at Birmingham Comprehensive Cancer Center. Her career includes basic science investigations and involvement in the conduct of scores of clinical trials, including 50 for targeted radionuclide therapy. Her activities are reflected in publications, memberships of scientific associations and she has served in numerous committees. Among her honors and awards, she has been selected for Best Doctor listings (greater than 10 years).

)

Univ. Alabama Med. Ctr.
Birmingham, AL
USA

B.C Nair
University of Texas MD Anderson Cancer Center
Houston
USA

G.L Nicolson (Biography
G.L Nicolson

Garth L. Nicolson, Ph.D., M.D. (H) is the President, Chief Scientific Officer and Professor Emeritus at the Institute for Molecular Medicine in Huntington Beach, California. Having published over 675 medical and scientific papers, including editing 20 books, he has served on the Editorial Boards of 30 medical and scientific journals. He has won many awards, including the Burroughs Wellcome Medal, Royal Society of Medicine (London), Stephen Paget Award, Metastasis Research Society, US National Cancer Institute Outstanding Investigator Award, and the Innovative Medicine Award (Canada). He is a Colonel (Honorary) of the US Army Special Forces and US Navy SEAL (Honorary) for Armed Forces and veterans’ illnesses.

)

The Institute for Molecular Medicine
Huntington Beach, CA
USA

R.F Ozols
Fox Chase Cancer Center
Philadelphia, PA
USA

H.I Pass
NYU School of Medicine and NCI Cancer Center
New York, NY
USA

S Pestka
Robert Wood Johnson Med. Sch.
Piscataway, NJ
USA

J.J Rafter
Karolinska Institutet
Huddinge
Sweden

A Ravaud
Hôpital Saint Andre
Bordeaux
France

R Rees
Nottingham Trent University
Nottingham
UK

G.V Sherbet
University Newcastle Upon Tyne
Newcastle upon Tyne
UK

E.J Stanbridge
Univ Calif. Irvine
Irvine, CA
USA

C.F. Stewart
St. Jude Children's Research Hospital
Memphis, TN
USA

M.M Taketo
Kyoto University Grad. Sch. Med
Kyoto
Japan

K.D Tew (Biography
K.D Tew

Dr. Tew received his undergraduate degree from the University of Wales and graduate training at the University of London, where he received his Ph.D., and later a Doctor of Science in recognition of his accomplishments in cancer research.

Currently, Dr.Tew is the John C. West Chair in Cancer Research and the Chairman of the Department of Pharmacology at the Medical University of South Carolina. He has appointments to a wide variety of peer-review committees, editorial boards, and academic and industry scientific advisory boards, is a Fellow of the American Association for the Advancement of Science (AAAS).

)

Medical University of South Carolina
Charleston, SC
USA

P. Vaupel
University of Mainz
Mainz
Germany

D.K Watson
Med. University S Carolina Hollings Canc. Ctr.
Charleston, SC
USA

T. Whiteside (Biography
T. Whiteside

Dr. Theresa Whiteside is a Professor of Pathology, Otolaryngology and Immunology at the University of Pittsburgh and member of the University of Pittsburgh Cancer Institute. She is a recognized expert in immune monitoring of patients with cancer and has authored over 575 peer-reviewed publications and 127 chapters as well as a book on human tumor-infiltrating lymphocytes, also co-editing several scientific books. She has trained 94 post-doctoral fellows from the United States and abroad.

Her research interests include tumor immunology and immunotherapy. Currently, she is investigating the role of regulatory T cells in cancer progression as well as contributions of tumor-derived exosomes (TEX) to dysfunction of CD8+ effector cells in the peripheral circulation of patients with cancer and in the tumor microenvironment

)

Univ. Pittsburgh Sch. Med
Pittsburgh, PA
USA

J.R Yannelli
Univ. Kentucky Sch. Med.
Lexington, KY
USA

A.A. Adjei
Mayo Clinic
Rochester, MN
USA

F. Balkwill
Barts & London Queen Mary's Sch. Med.& Dent
London
UK

J. Bergh
Karolinska Hosp. & Inst. Radiumhemmet
Stockholm
Sweden

M.V. Blagosklonny
New York Medical College
Hawthorne, NY
USA

E. Bouffet
Hosp. Sick Children
Toronto, ON
Canada

R.M. Bukowski
Cleveland Clinic Taussig Canc. Ctr
Cleveland, OH
USA

W.K Cavenee (Biography
W.K Cavenee

Dr. Cavenee is Distinguished Professor of Medicine at the University of California at San Diego and Director, Strategic Alliances-CNS of Ludwig Cancer Research with global responsibilities. He is an elected member/fellow of the National Academy of Sciences, the National Academy of Medicine, the Leopoldina German Academy of Science, the AACR Academy, the International Union Against Cancer, the American Society for Clinical Investigation and the American Academy of Microbiology. He has published more than 370 scientific papers and received more than 100 honors, most notably the Charles S.

)

University of California at San Diego
La Jolla, CA
USA

R. Clarke (Biography
R. Clarke

Robert Clarke, Ph.D., D.Sc. leads Georgetown University Medical Center’s high performance research community, expanding its extramural funding and promoting the efforts of its faculty. Also, he works in collaboration with the Georgetown University Graduate School of Arts and Sciences to cultivate and strengthen the research components of the University’s graduate programs and the quality of graduate biomedical education. Clarke is co-director of the Georgetown-Lombardi Comprehensive Cancer Center breast cancer program, a professor in the Department of Oncology, and an internationally known breast cancer researcher.

)

Georgetown Univ. Sch. Med.
Washington, DC
USA

K.A Cooney
Univ. Michigan Med. Sch.
Ann Arbor, MI
USA

J.M Daly
Temple University Sch. Med
Philadelphia, PA
USA

A. Deisseroth
Sidney Kimmel Cancer Center
San Diego, CA
USA

W.S. El-Deiry
University of Pennsylvania
Philadelphia, PA
USA

J.M. Ford
Stanford Univ. Sch. Med.
Stanford, NC
USA

D.K. Gaffney
University of Utah
Salt Lake City, UT
USA

G Gasparini
Azienda Complesso Ospedaliero San Filippo Neri
Rome
Italy

S.L Gerson
Case Western Reserve Univ.
Cleveland, OH
USA

R Giavazzi
Mario Negri Inst. Pharmacol Res.
Bergamo
Italy

A.K Godwin
Fox Chase Canc. Ctr.
Philadelphia, PA
USA

D.H Gutmann
Washington Univ. Sch. Med
St. Louis, MO
USA

C.H Heldin (Biography
C.H Heldin

Since 1986, C.-H. Heldin is the Branch Director of the Ludwig Institute for Cancer Research in Uppsala, Sweden, and since 1992 is also the professor in Molecular Cell Biology at Uppsala University. He obtained a PhD degree in Medical and Physiological Chemistry in 1980 from the University of Uppsala, where he continued to work until 1985 using a position sponsored by the Swedish Cancer Society. C.-H. Heldin is the chair of the Boards of the Nobel Foundation, the Science for Life Laboratory, and the European Molecular Biology Organization. He has published more than 600 scientific papers.

)

Ludwig Institute for Cancer Research
Uppsala
Sweden

A.N Houghton
Memorial Sloan-Kettering Cancer Center
New York, NY
USA

Y Ito
Kuma Hospital
Kobe
Japan

F.F Kadlubar
University of Arkansas
Little Rock, AR
USA

L Kelland
St. George Hosp. Sch. Med. Antisoma Res. Lab
London
UK

G Lopez-Berestein
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

H.T Lynch
Creighton University Sch. Med.
Omaha, NE
USA

M.J Mckeage
University of Auckland
Auckland
New Zealand

W.M Mendenhall
Univ. Florida Coll. Med.
Gainesville, FL
USA

L Milas
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

R Narayanan (Biography
R Narayanan

Ramaswamy Narayanan earned his Ph.D. in biochemistry in 1980 from the National University of Dublin, Ireland. He has worked at the NCI, CDC, the Yale University, Memorial Sloan Kettering Cancer Center, and at the Hoffmann-La Roche, Inc. He has published over 140 peer-reviewed publications and numerous book chapters. He is a Professor at Florida Atlantic University for the last seventeen years, where his work has led to two issued patents and the first Biotech spin-off company for the University. His research revolves around the genomics of cancer and other diseases.

)

Florida Atlantic University
Boca Raton, FL
USA

S Nishimura
University of Tsukuba
Tsukuba, Ibaraki
Japan

K Pantel (Biography
K Pantel

Prof Pantel is Chairman of the Institute of Tumour Biology at the University Medical Center Hamburg-Eppendorf. The institute is part of the Centre of Experimental Medicine and the University Cancer Center Hamburg (UCCH). The pioneer work of Prof Pantel in the field of cancer micrometastasis, circulating tumor cells and circulating nucleic acids (ctDNA, microRNAs) is reflected by more than 400 publications. He has been awarded the AACR Outstanding Investigator Award 2010, German Cancer Award 2010, and ERC Advanced Investigator Grant 2011. Moreover, Prof Pantel coordinates the European TRANSCAN group “CTC-SCAN”, the European IMI consortium CANCER-ID (www.cancer-id.eu) on blood-based “Liquid Biopsies”.

)

Univ. Klinikum Hamburg
Hamburg
Germany

N Pearce
Massey University
Wellington
New Zealand

M Pierotti
Pierotti
Milan
Italy

M.F Rajewsky
University of Essen Medical School
Essen
Germany

A Raz
Wayne State Univ. Sch. Med.
Detroit, MI
USA

J Schlom
National Cancer Institute, NIH
Bethesda, MD
USA

R. Soffietti
University of Turin
Turin
Italy

P.S. Steeg
National Cancer Institute NIH
Bethesda, MD
USA

Y.-J. Surh
Seoul National University
Seoul
South Korea

C.H. Takimoto
Cancer Therapy and Research Center
San Antonio, TX
USA

D.J. Tindall
Mayo Medical School
Rochester, MN
USA

C.L. Vecchia
Mario Negri Inst
Milan
Italy

S. Waxman
Mt. Sinai Sch. Med.
New York, NY
USA

P. Workman
Canc. Res. UK Ctr. Canc. Therapeut
Surrey
UK

W. Zhang
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

A. Almasan
Cleveland Clin. Fdn. Lerner Res. Inst
Cleveland, OH
USA

M. Bar-Eli
Univ. Texas MD. Anderson Canc. Ctr
TX
USA

I.D. Bernstein
Fred Hutchinson Canc. Res. Ctr
Seattle, WA
USA

H. Bleiberg
Inst. Jules Bordet
Brussels
Belgium

R.H. Brakenhoff
Free University of Amsterdam
Amsterdam
The Netherlands

G. Carruba
ARNAS-Civico
Palermo
Italy

P. Chandra
Klinikum der Universitat
Frankfurt
Germany

G Clayman
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

H Cortes-Funes
Med. Oncol. Serv. Hosp. University 12 de Octubre
Madrid
Spain

D.N. Danforth
National Cancer Institute, NIH
Bethesda, MD
USA

M Detmar
Massachusetts Gen. Hosp
Boston, MA
USA

P.B Fisher
Columbia University Coll. Phys. & Surg.
New York, NY
USA

H.S. Friedman (Biography
H.S. Friedman

Dr. Henry S. Friedman is an internationally renowned academic adult and pediatric neuro-oncologist who helps to lead The Preston Robert Tisch Brain Tumor Center at Duke University. He is the author of more than 500 peer reviewed articles, reviews, and book chapters and has presented extensively at both international and national meetings. He is the senior editor of CNS Oncology, was the Associate Editor for the Neuro-Oncology Section of Cancer for 15 years and is a reviewer for over 25 academic journals.

)

Duke Univ. Med. Ctr.
Durham, NC
USA

Q. Gao
Pharmaceutical Company Sanofi
Boston
USA

A.F Gazdar
University Texas SW Med. Ctr.
Dallas, TX
USA

A.J Giaccia (Biography
A.J Giaccia

Dr. Amato J. Giaccia obtained his Ph.D. in Pathology/Molecular Biology from the University of Pennsylvania in Philadelphia. He is a Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology. He also is the Director of Basic Science at the Stanford Cancer Institute and heads the Radiation Biology Program in Stanford’s Cancer Center. He co-authored the sixth & seventh editions of the textbook, “Radiation Biology for the Radiologist,” with Professor Eric Hall from Columbia. In addition, he is currently the “Jack, Lulu and Sam Willson Professor in Cancer Biology” in the Stanford University School of Medicine.

)

Stanford University
Stanford, CA
USA

A Giordano
Temple University
Philadelphia, PA
USA

S Grant
Virginia Commonwealth Univ. Med. Coll.
Richmond, VA
USA

K Haustermans
University Hospital Gasthuisberg
Leuven
Belgium

I Hellstrom
University of Washington
Seattle, WA
USA

D Ilson (Biography
D Ilson

Dr. Ilson is attending physician and member at Memorial Hospital, and professor of medicine at Weill-Cornell Medical College. His research interest is upper gastrointestinal cancer with a focus on esophageal cancer. His research focuses on the study of new agents in advanced esophageal cancer and in combined modality therapy. He sits on U.S. NCCN Gastric Cancer guideline panel, and the GI Cancer committees of Alliance/CALGB and NRG/RTOG. He is the former chair of the U.S. NCI Esophageal and Gastric Cancers Clinical Trial Task Force.

)

Memorial Sloan-Kettering Cancer Center
New York, NY
USA

E.M Jaffee
Johns Hopkins Univ. Sch. Med.
Baltimore, MD
USA

B Kaina (Biography
B Kaina

Dr. Bernd Kaina obtained his Ph.D. in genetics in 1976 from the Universtity of Halle, Germany. He completed his postdoctoral training at the Institute of Genetics in Gatersleben and continued his studies on DNA repair at the Department of Molecular Biology in Leiden, Netherlands, at the German Cancer Research Center in Heidelberg and, as a Heisenberg fellow, at the Department of Genetics of the Nuclear Research Center in Karlsruhe, Germany. In 1993 he was appointed full professor for molecular toxicology at the Institute of Toxicology of the University of Mainz, where he is since 2003, director of the institute. He is author of more than 280 scientific publications and serves as editorial board member and reviewer for several scientific journals.

)

University of Mainz
Mainz
Germany

D Khayat (Biography
D Khayat

Dr. Khayat received his medical degree from the Pierre and Marie Curie University in Paris, where he completed his doctorate in tumor immunology and was Chief Clinical Assistant for the Department of Medical Oncology. He has taught at The University of Texas MD Anderson Cancer Center, Pierre and Marie Curie University in France, and Sino‐French Institute of Onco‐Hematology in China. He has been a visiting professor at the Mount Sinai School of Medicine.

)

Salpetriere Hosp.
Paris
France

E Lundgren
Umea University
Umea
Sweden

F.M Marincola
Clinical Center, NIH
Bethesda, MD
USA

C.J Melief
Leiden University
Leiden
The Netherlands

S Merajver
Univ. Michigan Sch. Med.
Ann Arbor, MI
USA

H Mukhtar
Univ. Wisconsin
Madison, WI
USA

B.J Nickoloff
Loyola University of Chicago Med. Ctr.
Maywood, IL
USA

V Notario
Georgetown Univ. Med. Ctr.
Washington, DC
USA

M Park
McGill Univ. Hlth. Ctr.
Montreal, QC
Canada

L.J Penn (Biography
L.J Penn

Dr. Penn (PhD) is a cancer research scientist at the Princess Margaret Cancer Centre. Her research focuses on the molecular basis of cancer and the development and application of novel anti-cancer therapeutics. She is also a Professor in the Medical Biophysics Department at the University of Toronto and Director of the University Health Network’s Office of the Research Trainee.

Dr. Penn is a scientific advisor on several national/international review panels and is on several journal editorial boards. She holds the Canada Research Chair in Molecular Oncology and is the recipient of an Honorary Doctorate Degree from Linkoping University in Sweden.

)

Princess Margaret Hosp. Ontario Canc. Inst.
Toronto, ON
Canada

G.C Prendergast (Biography
G.C Prendergast

Dr. Prendergast is an international leader in cancer research with special expertise in the preclinical discovery and development of molecular cancer therapeutics, with a recent emphasis on immunomodulators such as IDO inhibitors now in multiple Phase I/II clinical trials. He is currently President and CEO of the Lankenau Institute for Medical Research (LIMR), which employs a unique ‘acapreneurial’ organizational model to integrate biotech start-up companies with non-profit laboratory and clinical groups to speed translation of discoveries to clinic.

)

Thomas Jefferson University
Wynnewood, PA
USA

M.J Ratain
Univ. Chicago Canc. Res. Ctr.
Chicago, IL
USA

G.H Reaman
Childrens Natl. Med. Ctr.
Washington, DC
USA

A.K Shamsuddin (Biography
A.K Shamsuddin

Dr. AbulKalam M. Shamsuddin is Professor of Pathology at the University of Maryland School of Medicine in Baltimore. He received his medical degree from Dhaka University, and PhD from University of Maryland. He is the pioneering scientist to demonstrate the anti-cancer and immune enhancing function of inositol and inositol hexaphosphate (www.ip-6.net).

Dr. Shamsuddin has published several books, many book-chapters and numerous scientific papers. He serves in the Editorial Board of several cancer related journals; and is a highly sought after speaker in international scientific meetings.

)

Univ. Maryland Sch. Med.
Baltimore, MD
USA

D.A. Spandidos
Univ. Crete Sch. Med.
Crete
Greece

G.S. Stein
Univ. Massachusetts Sch. Med.
Worcester, MA
USA

E. Tahara
Hiroshima Cancer Seminar Foundation
Hiroshima
Japan

Z.Y Tang
Fudan University
Shanghai
China

E.L. Travis
Univ. Texas MD. Anderson Canc. Ctr.
Houston, TX
USA

H. Wallace
Royal Hospital for Sick Children
Edinburgh
UK

R.R. Weichselbaum
The University of Chicago
Chicago, IL
USA

J. Xiang
Saskatoon Cancer Center
Saskatoon
Canada


Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals





Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science